Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 309 | 188 | 187 | 172 | 87 |
| Accounts receivable | 175 | -301 | -240 | -96 | -19 |
| Other Working Capital | 217 | -367 | -555 | -552 | 264 |
| Other Operating Activity | -2,330 | -2,094 | -3,204 | -3,990 | -4,171 |
| Operating Cash Flow | $-1,629 | $-2,574 | $-3,812 | $-4,465 | $-3,839 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -11 | -49 | 0 | -4 |
| Purchase Sale Intangibles | N/A | N/A | 0 | -479 | -237 |
| Investing Cash Flow | $-3 | $-11 | $-49 | $-479 | $-241 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,886 | N/A | N/A | N/A | N/A |
| Debt Repayment | -140 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 1,790 | 4,552 | 4,254 | 948 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 720 |
| Financing Cash Flow | $1,746 | $1,790 | $4,552 | $4,254 | $1,668 |
| Beginning Cash Position | 370 | 1,165 | 473 | 1,164 | 3,576 |
| End Cash Position | 485 | 370 | 1,165 | 473 | 1,164 |
| Net Cash Flow | $115 | $-795 | $691 | $-691 | $-2,412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,629 | -2,574 | -3,812 | -4,465 | -3,839 |
| Capital Expenditure | -3 | -11 | -49 | -479 | -242 |
| Free Cash Flow | -1,632 | -2,585 | -3,861 | -4,944 | -4,081 |